The European Medicines Agency this week approved a special vaccine for omikron for registration. According to the Ministry of Health, they should arrive in the Czech Republic by the end of September. Therefore, these specialized vaccines should be used for the third and fourth doses.
Specialized vaccines Comirnaty Original / Omicron BA.1 and Spikevax Bivalent Original / Omicron BA.1 are intended for all people over the age of 12, announced the State Institute for Drug Control (SÚKL). According to the spokesperson of the Ministry of Health, Ondřej Jakob, in the coming months it will replace the original vaccination, which is currently used in booster doses.
“We are still waiting for some actions, but I am convinced that they will take place in September,” Jakob told TN.cz about the specialized vaccines. According to the earlier statements of the Minister of Health Vlastimil Válek (TOP 09), about three million doses should arrive. “We have been promised that as soon as possible, Pfizer or Moderna will send them to us,” added Jakob.
So the question arises whether people who only have two or three doses should wait a few more weeks. “Those at risk, which is 60+ or those who have some diseases, should not wait,” said Jakob. “For the others, of course, it’s up to everyone,” he added, adding that the vaccines currently used are already effective.
“The vaccines are modified to better match the currently circulating variants of the SARS-CoV-2 virus. The modified vaccines can thus extend protection against different variants and are therefore expected to help maintain optimal protection against covid-19 as the virus evolves,” SÚKL pointed out. “In particular, they were more effective in triggering an immune response against the BA.1 subvariant than the original vaccines,” he added.
Even according to SÚKL, the original vaccination is still effective in preventing serious illness, hospitalization and death. “Other modified vaccines containing different variants, such as the omikron BA.4 and BA.5 subvariants, are currently under review by the EMA or will soon be submitted and, if registered, will further expand the spectrum of available vaccines,” he said.
The ministry launched registration for the fourth batch in mid-August: